First Patient Enrolled in reMARQable Clinical Study Evaluating the Safety and Efficacy of Multi-Elec
First Patient Enrolled in reMARQable Clinical Study Evaluating the Safety and Efficacy of Multi-Electrode nMARQ™ Pulmonary Vein Isolation System™ in the Treatment of Paroxysmal Atrial Fibrillation ...
DIAMOND BAR, Calif.--(BUSINESS WIRE)--Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, today announced the first patient has been enrolled in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback